Adenocarcinoma of the Prostate

Showing 1 - 25 of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Androgen suppression plus radiation therapy
  • Montreal, Quebec, Canada
  • +1 more
Jan 30, 2023

Adenocarcinoma of the Prostate Trial in United States (Muscadine Plus, Placebos)

Terminated
  • Adenocarcinoma of the Prostate
  • Muscadine Plus
  • Placebos
  • Duarte, California
  • +12 more
Dec 6, 2022

Adenocarcinoma of the Prostate Trial in Washington, Baltimore, Bethesda (Radiation Therapy, Androgen Deprivation Therapy (ADT))

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Radiation Therapy
  • Androgen Deprivation Therapy (ADT)
  • Washington, District of Columbia
  • +2 more
Oct 25, 2022

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Beverly Hills, Los Angeles, Pasadena

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +5 more
  • phenelzine sulfate
  • +2 more
  • Beverly Hills, California
  • +3 more
Aug 19, 2022

Adenocarcinoma of the Prostate, Stage III Prostate Cancer Trial in Los Angeles (radiation, other, drug)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Stage III Prostate Cancer
  • stereotactic body radiation therapy
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Apr 28, 2022

Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Los Angeles (behavioral, dietary

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +3 more
  • behavioral dietary intervention
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Apr 4, 2022

Adenocarcinoma of the Prostate Trial in Jacksonville (HR-A, HR-B)

Recruiting
  • Adenocarcinoma of the Prostate
  • HR-A
  • HR-B
  • Jacksonville, Florida
    University of Florida Health Proton Therapy Institute
Mar 14, 2022

Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +3 more
  • anti-PSMA monoclonal antibody MDX1201-A488
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Prostate Cancer, Adenocarcinoma of the Prostate Trial in Providence (Olaparib Pill, Prostatectomy)

Terminated
  • Prostate Cancer
  • Adenocarcinoma of the Prostate
  • Olaparib Pill
  • Prostatectomy
  • Providence, Rhode Island
    Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals
Feb 2, 2022

Adenocarcinoma of the Prostate Trial in United States (Enzalutamide, SRT)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Washington, District of Columbia
  • +8 more
Feb 3, 2022

Adenocarcinoma of the Prostate Trial in United States (sipuleucel-T)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • sipuleucel-T
  • Gilbert, Arizona
  • +55 more
Jan 18, 2022

Prediction of Lymph Node Invasion for Prostate Adenocarcinoma

Recruiting
  • Adenocarcinoma of the Prostate
    • Brest, France
      CHRU Brest
    Jan 17, 2022

    Prostate Cancer, Adenocarcinoma of the Prostate Trial in Baltimore (Brachytherapy)

    Active, not recruiting
    • Prostate Cancer
    • Adenocarcinoma of the Prostate
    • Brachytherapy
    • Baltimore, Maryland
      The SKCCC at Johns Hopkins
    Nov 4, 2021

    Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)

    Recruiting
    • Adenocarcinoma of the Prostate
    • Stereotactic Radiosurgical Boost
    • +2 more
    • Sacramento, California
      UC Davis Sacramento Cancer Center Dept of Radiation Oncology
    Sep 24, 2021

    Circulating Prostate Cells Among Adenocarcinoma Patients

    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • EPISPOT detection of the number of circulating cells
    • CellSearch detection of the number of circulating, functional, prostate cells
    • Nîmes Cedex 09, Gard, France
    • +4 more
    Aug 4, 2021

    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (drug, radiation,

    Completed
    • Adenocarcinoma of the Prostate
    • +3 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Aug 3, 2021

    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Los Angeles (dietary supplement,

    Completed
    • Adenocarcinoma of the Prostate
    • +6 more
    • green tea extract
    • +4 more
    • Los Angeles, California
    • +1 more
    Jun 22, 2021

    Adenocarcinoma of the Prostate Trial in Dijon (Stereotactic Radiotherapy with Linac MRI)

    Recruiting
    • Adenocarcinoma of the Prostate
    • Stereotactic Radiotherapy with Linac MRI
    • Dijon, France
      Centre Georges François Leclerc
    May 27, 2021

    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,

    Completed
    • Adenocarcinoma of the Prostate
    • +3 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 2, 2021

    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus

    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • +2 more
    • Birmingham, Alabama
    • +3 more
    Mar 2, 2021

    Adenocarcinoma of the Prostate Trial in United Kingdom (Active CTC Assessment)

    Terminated
    • Adenocarcinoma of the Prostate
    • Active CTC Assessment
    • Sutton, Surrey, United Kingdom
    • +3 more
    Jan 5, 2021

    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Orange (Docetaxel, Lycopene)

    Completed
    • Adenocarcinoma of the Prostate
    • +5 more
    • Orange, California
      Chao Family Comprehensive Cancer Center
    Dec 30, 2020

    Prostate Cancer, Adenocarcinoma of the Prostate, Locally Advanced Prostate Carcinoma Trial in Belgium (standard of care)

    Recruiting
    • Prostate Cancer
    • +3 more
    • standard of care
    • Dendermonde, Oost-Vlaanderen, Belgium
    • +3 more
    Jan 4, 2021

    Metastatic Castration-resistant Prostate Cancer, Adenocarcinoma of the Prostate Trial in Pécs (Selegiline, Docetaxel)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Adenocarcinoma of the Prostate
    • Pécs, Baranya, Hungary
      University of Pécs, Clinical Centre, Department of Oncotherapy
    Oct 7, 2020